aestheticmedguideAestheticMedGuide
Skin

How Practices Should Vet Scar Gel, Liquid Bandage, and Post-Procedure Products

How practices should vet post-procedure adjuncts — scar gels, liquid bandages, cooling sprays — covering claims substantiation, the device/drug/cosmetic boundary, and what not to overpromise.

Ran Chen
Ran Chen
8 min read · Published · Evidence-based

After an aesthetic procedure — laser resurfacing, microneedling, chemical peel, injectable session, or minor excision — the clinician often recommends or applies a post-procedure product: a silicone scar gel, a hyaluronic acid liquid bandage, a cooling spray, a cyanoacrylate adhesive. These adjuncts are not the treatment itself, but they influence healing, patient satisfaction, and the practice's liability profile.

The problem: the post-procedure product category spans medical devices, cosmetics, over-the-counter drugs, and unregulated "wellness" products — often within the same product display. A practice that stocks and recommends the wrong category of product can face regulatory exposure, patient harm, or at minimum, a credibility problem.

This article explains how aesthetic practices should evaluate adjunctive post-procedure products, using VEMERIX's wound and skin line — which includes a scar reduction gel, hyaluronic liquid bandage, cooling spray, and medical adhesive — as a running case study.

The Device/Drug/Cosmetic Boundary

The most important distinction for any post-procedure product is its regulatory classification. In the United States, the FDA sorts topically applied products into three broad categories:

  • Medical devices — Products that achieve their primary intended purpose through physical (not chemical or metabolic) means. Silicone scar sheeting, for example, was classified by FDA as a Class I medical device for management of hypertrophic and keloid scars in 2004. Liquid wound dressings that form a physical barrier may also be regulated as devices.
  • Drugs — Products intended to diagnose, cure, mitigate, treat, or prevent disease, or that achieve their effect through chemical action. A scar gel that claims to "reduce inflammation through corticosteroid release" would be regulated as a drug, even if it is also a physical barrier.
  • Cosmetics — Products intended to cleanse, beautify, or promote attractiveness. A moisturizer labeled "post-procedure soothing cream" that makes no medical claims and contains no drug ingredients is a cosmetic.

The boundary is not always clean. A single product can be both a cosmetic and a drug (a "cosmeceutical" in marketing terms, though FDA does not recognize that category). A wound dressing that contains an antimicrobial preservative may be a device if the antimicrobial's role is solely product preservation — but if the antimicrobial is intended to treat or prevent infection in the wound, the product crosses into drug territory.

What this means for practices: Before stocking any post-procedure product, read its regulatory classification. A silicone scar gel classified as a Class II medical device in one market may be sold as a cosmetic in another. VEMERIX's scar reduction gel, for instance, is registered as an NMPA Class II medical device in China — but a US practice cannot rely on that classification for domestic compliance. Verify the product's FDA status before recommending it to patients.

Claims Substantiation: What Can You Actually Say?

The claims a practice can make about a post-procedure product are bounded by both the product's regulatory classification and the evidence supporting those claims.

Silicone-based scar products have the strongest evidence base among topical scar adjuncts. A systematic review published in the Journal of Cutaneous and Aesthetic Surgery found that topical silicone gel produced measurable improvements in scar texture, color, and height, with reported reductions of 86% in texture, 84% in color, and 68% in scar height in clinical studies. The American Academy of Dermatology recommends keeping wounds moist with petroleum jelly or similar occlusive products and considering silicone gel sheets for larger wounds as part of proper wound care.

But the evidence for many other post-procedure adjuncts is thinner. Cooling sprays, for example, may provide temporary comfort, but few have published clinical data demonstrating improved healing outcomes. Hyaluronic acid liquid bandages form a physical film that may support a moist wound environment — but the degree to which this translates to faster healing or better cosmetic outcomes compared to standard petrolatum-based care is product-specific and often unsupported by controlled studies.

The rule for practices: If you cannot cite a published study or an FDA-cleared indication for a specific claim, do not make the claim to patients. "This product may help keep the area moist during healing" is supportable for an occlusive product. "This product will prevent scarring" is not — and exposes the practice to liability.

Ingredient Disclosure and Patient Safety

Post-procedure skin is compromised. The barrier is disrupted, inflammation is present, and the risk of irritant and allergic contact dermatitis is elevated compared to intact skin. This makes ingredient transparency critical.

Practices should require the following from any product they stock for post-procedure use:

  • Full ingredient list — not just the "active" ingredients. Preservatives, fragrances, and botanical extracts can all trigger reactions on compromised skin.
  • Known allergens flagged — Products applied to healing skin should avoid common contact allergens where possible.
  • Stability and expiration data — Especially for products marketed as sterile or preservative-free.

When evaluating a new product line, request the Safety Data Sheet (SDS) and the product's IFU. If the manufacturer cannot or will not provide these, that is a disqualifying signal.

Post-Laser and Post-Injection Protocols

Different procedures create different post-care needs, and a single product rarely suits all of them:

  • After ablative or fractional laser resurfacing: The skin is an open wound. Petrolatum-based occlusive care is the standard supported by dermatologic literature. Silicone-based products are typically introduced only after re-epithelialization is complete — usually 5–10 days post-procedure, depending on depth.
  • After non-ablative laser or RF microneedling: The barrier is disrupted but not fully breached. A hyaluronic acid liquid bandage or gentle occlusive moisturizer may be appropriate from day one, depending on the product's indications.
  • After injectables (neuromodulators, fillers): Injection sites are minimally compromised. A cooling spray may reduce discomfort, but most patients need nothing beyond gentle cleansing and sun protection. Avoid applying any occlusive product that could interfere with product diffusion in the first 24 hours.
  • After chemical peels: The protocol depends on peel depth. Superficial peels may tolerate light moisturization immediately; medium-depth peels require a re-epithelialization phase before any active ingredients are introduced.

VEMERIX lists its cooling spray as a "burn and scald protective moisture hydrogel," its hyaluronic liquid bandage as a "sodium-hyaluronate film for minor wounds," and its scar reduction gel for post-procedure healing. Each of these has a different appropriate window of use. Practices should not assume that "post-procedure" means the same protocol for every procedure type.

Patient Instructions and Expectation Management

A practice that recommends a post-procedure product is responsible for giving the patient clear instructions on:

  • When to start and stop using the product. Silicone scar gel, for example, is typically recommended for a minimum of 12 hours per day contact time for 2–3 months on closed scars. Applying it to an open wound is contraindicated.
  • What to expect. A scar gel does not erase scars. It may improve their appearance. The patient needs to hear this before they attribute an imperfect outcome to the product — or to the procedure.
  • When to call the office. Contact dermatitis, prolonged erythema, or signs of infection after product application should prompt an office visit, not a product swap.

Inventory Controls and Shelf Life

Post-procedure products are often purchased in bulk and stored in treatment rooms. Practices should:

  • Track expiration dates, especially for sterile or preservative-free products.
  • Store products per the manufacturer's temperature and humidity specifications.
  • Avoid decanting products into unlabeled containers — a practice that creates both contamination risk and documentation gaps.

What Not to Overpromise

The strongest caution in this entire category is about claims. A post-procedure product that "supports healing" is a reasonable framing. A post-procedure product that "accelerates recovery," "prevents scarring," or "enhances results" is making a clinical claim that requires evidence the manufacturer may not have.

Practices that sell or recommend adjunctive products are not just retailers — they are clinicians whose recommendations carry the weight of clinical authority. The gap between what a product label says and what a practice implies to a patient is where liability lives.

VEMERIX's wound and skin products are positioned for outpatient and household use, available OTC in China and through cross-border e-commerce. When a US-based practice evaluates any imported product line, the relevant question is not "what is this registered as in the country of origin?" but "what is this product's status under FDA regulations, and what claims can I legally and ethically make to my patients?"

Sources

Topics
Topical SkincareSafetyRegulatory
Ran Chen
Contributing Editor
Ran Chen

Founder, AestheticMedGuide. Life-sciences operator covering aesthetic devices, injectables, and the industry behind them. Previously global market-access lead across pharma and medtech.

Follow on LinkedIn →

Keep reading from Skin

See all →
Providers · 13 min read

Med Spa Employee vs. Independent Contractor: How to Classify Workers Correctly

Misclassifying nurse injectors and estheticians as 1099 contractors exposes med spas to back taxes, penalties, and coverage gaps. How IRS and state…

Providers · 12 min read

Med Spa Malpractice Insurance: What It Covers, What It Costs, and Where the Gaps Hide

Malpractice insurance for medical spas: what policies actually cover, typical costs by practice size, common exclusions, and why your medical…

Providers · 10 min read

How to Find a Medical Director for Your Med Spa: State Rules, CPOM, and the Hiring Process

How to find, vet, and hire a medical director for a med spa: state CPOM rules, supervision requirements, where to search, and what red flags to avoid.